Bioprocess Development for Mass Production of Size-Controlled Human Pluripotent Stem Cell Aggregates in Stirred Suspension Bioreactor
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Current protocols for the scalable suspension culture of human pluripotent stem cells (hPSCs) are limited by multiple biological and technical challenges that need to be addressed before their use in clinical trials. To overcome these challenges, we have developed a novel bioprocess platform for large-scale expansion of human embryonic and induced pluripotent stem cell lines as three-dimensional size-controlled aggregates. This novel bioprocess utilizes the stepwise optimization of both static and dynamic suspension culture conditions. After screening eight xeno-free media in static suspension culture and optimizing single-cell passaging in dynamic conditions, the scale-up from a static to a dynamic suspension culture in the stirred bioreactor resulted in a two- to threefold improvement in expansion rates, as measured by cell counts and metabolic activity. We successfully produced size-specific aggregates through optimization of bioreactor hydrodynamic conditions by using combinations of different agitation rates and shear protectant concentrations. The expansion rates were further improved by controlling oxygen concentration at normoxic conditions, and reached a maximum eightfold increase for both types of hPSCs. Subsequently, we demonstrated a simple and rapid scale-up strategy that produced clinically relevant numbers of hPSCs (∼2×10(9) cells) over a 1-month period by the direct transfer of "suspension-adapted frozen cells" to a stirred suspension bioreactor. We omitted the required preadaptation passages in the static suspension culture. The cells underwent proliferation over multiple passages in the demonstrated xeno-free dynamic suspension culture while maintaining their self-renewal capabilities, as determined by marker expressions and in vitro spontaneous differentiation. In conclusion, suspension culture protocols of hPSCs could be used to mass produce homogenous and pluripotent undifferentiated cells by identification and optimization of key bioprocess parameters that are complemented by a simple and rapid scale-up platform.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055 · cited 1×
“10,15,16 17–19 However, results from these first attempts have shown (1) significant cell loss after passaging as a single-cell inoculated suspension culture; (2) irreproducible results for plur-ipotency and karyotype normality in different cell lines; (3) heterogeneous aggregate formation and…”
Chemically defined conditions for human iPSC derivation and culture
Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M., Ruotti, V., Probasco, M. D., Smuga-Otto, K., Howden, S. E., Diol, N. R., Propson, N. E., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1593 · Cited by 1,447
Scalable Stirred-Suspension Bioreactor Culture of Human Pluripotent Stem Cells
Kehoe, D. E., Jing, D., Lock, L. T., & Tzanakakis, E. S. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0454 · Cited by 264 · cited 2×
“30–32 However, we did not find any detailed information on optimizing inoculation densities for hPSC cultures.”
Niebruegge, S., Bauwens, C. L., Peerani, R., Thavandiran, N., Masse, S., Sevaptisidis, E., Nanthakumar, K., Woodhouse, K., Husain, M., Kumacheva, E., et al. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22065 · Cited by 222 · cited 3×
“Our proposed method is more scalable than other technologies developed for cell aggregate size control such as microwell-mediated control, hanging drops, and micro printing technologies (33-35).”
Cited by
Scientific, sustainability and regulatory challenges of cultured meat
Post, M. J., Levenberg, S., Kaplan, D. L., Genovese, N., Fu, J., Bryant, C. J., Negowetti, N., Verzijden, K., & Moutsatsou, P. (2020) · Nature Food · doi:10.1038/s43016-020-0112-z · Cited by 783
Microcarriers for Upscaling Cultured Meat Production
Bodiou, V., Moutsatsou, P., & Post, M. J. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.00010 · Cited by 272
Progress and challenges in large-scale expansion of human pluripotent stem cells
Kropp, C., Massai, D., & Zweigerdt, R. (2017) · Process Biochemistry · doi:10.1016/j.procbio.2016.09.032 · Cited by 167
“This operation mode, which is also typical for the conventional PSC cultivation in 2D in a dish, was successfully applied by several groups using both microcarrier- [54,55,81,84,85] and aggregate-based suspension culture [45,63,65,66,80,86].”
Nath, S. C., Nagamori, E., Horie, M., & Kino-oka, M. (2017) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-016-1680-z · Cited by 53
“Moreover, suspension culture of hiPSCs in a bioreactor requires a large volume of culture medium, since spent medium is replaced daily with fresh medium to reduce the accumulation of lactic acid, ammonium (NH4 ), and other toxic metabolites, which increase with an increase in cell density [20].”
BackgroundBiological effects of culture substrates on human pluripotent stem cells
Hayashi, Y., & Furue, M. K. (2016) · Stem Cells International · doi:10.1155/2016/5380560 · Cited by 50
Nath, S. C., Tokura, T., Kim, M., & Kino‐oka, M. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26526 · Cited by 19
“conventional aggregate suspension culture (Abbasalizadeh et al., 2012; Amit et al., 2010; Olmer et al., 2012), a value significantly lower than that of the current study.”
InfluentialExpansion of human pluripotent stem cells
Adil, M. M., & Schaffer, D. V. (2017) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2016.11.002 · Cited by 17
Yehya, H., Wells, A., Majcher, M., Nakhwa, D., King, R., Senturk, F., Padmanabhan, R., Jensen, J., & Bukys, M. A. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03973-0 · Cited by 7
Metadata
- Authors
- Abbasalizadeh, S., Larijani, M. R., Samadian, A., & Baharvand, H.
- Venue
- Tissue Engineering Part C: Methods
- Publisher
- SAGE Publications
- Published
- 2012-11
- Volume
- 18
- Issue
- 11
- Pages
- 831-851
- ISSN
- 1937-3384 (ISSN-L)
- 1937-3392
- OpenAlex
- W2028531378
- Cited by
- 145
- References
- 4
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.